MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
MEDIK is a well-established provider of premium modular glass wall systems for operating rooms (ORs), intensive care units (ICUs) and other clinical environments, with its MEDglas® solutions successfully installed in more than 54 countries. Globally, MEDIK designs room concepts tailored to clients’ needs in ORs, endoscopy rooms, CT, MRI and ICU environments, using glass and light as core elements. MEDIK designs and produces walls, doors, ceilings, cabinets and floors. The company is unique in this sector because it supports the entire process, from planning to the handover of the finished construction. MEDIK’s senior executives have more than 30 years of experience in medical engineering. The company employs approximately 50 people, recently promoted a long-tenured employee to its top management team and operates globally with offices in Germany, Switzerland and Dubai.
STERIS is one of the world’s leading healthcare and life sciences companies, with a strong focus on infection prevention and a broad portfolio of reprocessing, sterilization and surgical solutions.
Oaklins’ team in Germany acted as the exclusive advisor to the shareholders of MEDIK Hospital Design Group on its sale to STERIS.
Thomas Lütke-Kappenberg
Co-founder and seller, MEDIK Hospital Design Group
Contáctese con el equipo de la transacción
Transacciones relacionadas
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Aprenda másEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Aprenda másOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Aprenda más